Additional $750,000 Loan Facility from Barvest Ventures Melbourne, Australia – 30 October 2026: Adherium Limited (ASX:ADR) (“Adherium” or “the Company”), a global leader in digital respiratory management and developer of the US FDA-cleared Hailie® Smartinhaler® has received additional...
Additional $750,000 Loan Facility from Barvest Ventures
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Adherium Ltd. has announced a new loan facility from Barvest Ventures amounting to additional funding for working capital requirements. This loan is separate from a previous facility and is unsecured with a specified interest rate and repayment terms. The Board believes this option is preferable to alternatives due to less dilution for shareholders and quicker execution. The terms of the loan have been negotiated at arm's length and do not require shareholder approval.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from Adherium
- Notice of Annual General Meeting/Proxy Form
- Partnership with Florida Lung, Asthma & Sleep Specialists
- Appointment of Chief Financial Officer
- AUD$700,000 Short-Term Loan Facility from Barvest Ventures
- Appendix 4G & Corporate Governance Statement
Later from Adherium
All Adherium news releasesFollow Adherium into a list and get an email when it puts out news.
Follow Adherium